Log In
Print
BCIQ
Print
Print this Print this
 

etanercept (Etacept)

  Manage Alerts
Collapse Summary General Information
Company Cipla Ltd.
DescriptionBiosimilar version of Enbrel etanercept, a recombinant p75 tumor necrosis factor (TNF) receptor linked to the Fc portion of human IgG1 (TNFr:Fc)
Molecular Target Tumor necrosis factor (TNF) alpha
Mechanism of ActionBiosimilar
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentMarketed
Standard Indication Autoimmune (unspecified)
Indication DetailsTreat rheumatic disorders
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today